0001237899-12-000056.txt : 20120521
0001237899-12-000056.hdr.sgml : 20120521
20120521153006
ACCESSION NUMBER: 0001237899-12-000056
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120518
FILED AS OF DATE: 20120521
DATE AS OF CHANGE: 20120521
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHOOTER ERIC M
CENTRAL INDEX KEY: 0001225472
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 12858689
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0305
4
2012-05-18
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001225472
SHOOTER ERIC M
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
0
0
0
Common Stock
2012-05-18
4
M
0
2000.0
18.61
A
2000.0
D
Common Stock
2012-05-18
4
S
0
2000.0
124.04
D
0.0
D
Common Stock
2012-05-21
4
M
0
8000.0
18.61
A
8000.0
D
Common Stock
2012-05-21
4
S
0
8000.0
123.23
D
0.0
D
Common Stock
2012-05-21
4
M
0
10000.0
24.41
A
10000.0
D
Common Stock
2012-05-21
4
S
0
10000.0
124.07
D
0.0
D
Common Stock
5000.0
I
by Trust
Non-Qualified Stock Option (right to buy)
18.61
2012-05-18
4
M
0
2000.0
D
2019-01-02
Common Stock
2000.0
8000.0
D
Non-Qualified Stock Option (right to buy)
18.61
2012-05-21
4
M
0
8000.0
D
2019-01-02
Common Stock
8000.0
0.0
D
Non-Qualified Stock Option (right to buy)
24.41
2012-05-21
4
M
0
10000.0
D
2020-01-04
Common Stock
10000.0
5000.0
D
Represents volume-weighted average price of sales of 2,000 shares of Company stock on May 18, 2012 at prices ranging from $124.05 to $124.08. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 18, 2012 at each separate price.
Represents volume-weighted average price of sales of 8,000 shares of Company stock on May 21, 2012 at prices ranging from $123.00 to $123.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2012 at each separate price.
Represents volume-weighted average price of sales of 10,000 shares of Company stock on May 21, 2012 at prices ranging from $124.00 to $124.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2012 at each separate price.
The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant
Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
/s/**Eric M. Shooter
2012-05-21